Medico Intercontinental Ltd
Medico Intercontinental Ltd Formerly Known as M/S. Intercontinental Leasing & Finance Company Limited) was incorporated in 1984. Currently, they are providing a platform to all research based biopharmaceutical companies reaching their Novel and innovative therapies. The Company is into the business of trading various medicines. [1] [2]
- Market Cap ₹ 44.9 Cr.
- Current Price ₹ 44.9
- High / Low ₹ 122 / 39.0
- Stock P/E 11.5
- Book Value ₹ 43.0
- Dividend Yield 0.22 %
- ROCE 16.6 %
- ROE 13.4 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Stock is trading at 1.05 times its book value
- Company is expected to give good quarter
Cons
- Company has high debtors of 157 days.
- Working capital days have increased from 101 days to 144 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|
0.00 | 9.95 | 81.93 | 69.74 | 74.26 | 76.23 | 84.66 | |
0.34 | 9.29 | 77.57 | 64.97 | 69.25 | 70.97 | 79.03 | |
Operating Profit | -0.34 | 0.66 | 4.36 | 4.77 | 5.01 | 5.26 | 5.63 |
OPM % | 6.63% | 5.32% | 6.84% | 6.75% | 6.90% | 6.65% | |
0.39 | 0.36 | 0.05 | 0.18 | 0.31 | 0.51 | 0.51 | |
Interest | 0.00 | 0.01 | 1.10 | 1.28 | 0.88 | 0.62 | 0.43 |
Depreciation | 0.00 | 0.00 | 0.10 | 0.14 | 0.21 | 0.20 | 0.27 |
Profit before tax | 0.05 | 1.01 | 3.21 | 3.53 | 4.23 | 4.95 | 5.44 |
Tax % | 40.00% | 26.73% | 26.17% | 26.91% | 26.71% | 27.07% | |
0.03 | 0.74 | 2.36 | 2.58 | 3.10 | 3.61 | 3.92 | |
EPS in Rs | 0.09 | 2.28 | 7.26 | 7.94 | 9.54 | 3.61 | 3.92 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.77% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -2% |
TTM: | 37% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 161% |
3 Years: | 15% |
TTM: | 13% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | -16% |
3 Years: | 17% |
1 Year: | -45% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 23% |
3 Years: | 20% |
Last Year: | 13% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|
Equity Capital | 3.25 | 3.25 | 3.25 | 3.25 | 3.25 | 10.00 | 10.00 |
Reserves | 0.02 | 0.75 | 3.11 | 6.29 | 9.39 | 31.19 | 32.98 |
0.02 | 0.11 | 13.66 | 9.31 | 8.73 | 4.72 | 5.82 | |
0.62 | 5.02 | 16.02 | 11.80 | 10.55 | 12.97 | 8.17 | |
Total Liabilities | 3.91 | 9.13 | 36.04 | 30.65 | 31.92 | 58.88 | 56.97 |
0.01 | 0.00 | 1.68 | 2.35 | 2.36 | 2.57 | 2.47 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.16 | 0.01 | 0.02 | 0.02 |
3.90 | 9.13 | 34.36 | 28.14 | 29.55 | 56.29 | 54.48 | |
Total Assets | 3.91 | 9.13 | 36.04 | 30.65 | 31.92 | 58.88 | 56.97 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|
0.02 | 0.93 | -13.82 | 5.82 | 3.85 | -10.10 | |
0.00 | 0.00 | 0.00 | -0.94 | -1.30 | -5.38 | |
0.00 | 0.09 | 13.42 | -5.14 | -1.20 | 20.41 | |
Net Cash Flow | 0.02 | 1.02 | -0.40 | -0.26 | 1.35 | 4.92 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|
Debtor Days | 237.34 | 101.44 | 94.10 | 84.25 | 157.29 | |
Inventory Days | 0.00 | 25.84 | 45.69 | 57.71 | 47.27 | 52.03 |
Days Payable | 201.37 | 73.54 | 66.83 | 50.21 | 66.73 | |
Cash Conversion Cycle | 61.81 | 73.59 | 84.98 | 81.31 | 142.58 | |
Working Capital Days | 78.14 | 74.44 | 81.07 | 77.36 | 143.93 | |
ROCE % | 27.57% | 35.72% | 24.75% | 25.41% | 16.56% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Resignation of Director
1d - Of Resignation of Mr. Nikul D Shah, Independent Director of the Company.
-
Announcement under Regulation 30 (LODR)-Meeting Updates
9 Apr - Outcome of Board Meeting and Compliances of Regulation 30 of SEBI LODR, 2015.
- Board Meeting Outcome for Outcome Of Board Meeting And Compliances Of Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015. 9 Apr
-
Compliances - PCS Certificate As On 31.03.2024
8 Apr - Submission of Compliance Certificate pursuant to Reg. 40(9) of SEBI LODR, 2015 issued by PCS for the financial year ended 31.03.2024.
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 3 Apr
About[1]
Medico is engaged in trading of Pharmaceutical products. In past few years, their core portfolio has been textile products. Current management brings expertise in the pharma industry and so the company has diversified to a pharma company.